Along the way, Moderna has racked up nearly $2.5 billion in funding from the U.S. government, including a deal to supply 100 million doses of its vaccine. Moderna vs Pfizer vaccine: How do they compare? Moderna's experimental coronavirus vaccine is based on an approach where messenger RNA (mRNA) is engineered to create a specific protein that mirrors the spike protein on SARS-CoV-2, the virus that causes COVID-19. Vaccine developers have plans to perform periodic tests by drawing blood from some volunteers to see their antibody levels. Since both the vaccines are new, there might be a possibility of offering at least one booster dose after the initial vaccination’s first two dosages. While severe reactions were not reported in clinical trials, it is essential to note that the FDA does not currently advise individuals with life-threatening allergies to receive the vaccination at this time. Pfizer vs. Moderna: Is one better than the other? Moderna’s clinical trial had 30,350 participants, Pfizer’s 36,621. Only two coronavirus vaccines have a realistic possibility of becoming available by the end of 2020. Vaccine developers have plans to perform periodic tests by drawing blood from some volunteers to see their antibody levels. It has 90 clinical programs, with four of those awaiting regulatory approval and another 23 in late-stage testing. During its last stage of clinical trial, the Moderna vaccine was 94.1% effective at preventing symptomatic Covid-19. In such a situation, there might be a recommended booster shot at some interval. While the deal will also reduce Pfizer's dividend a little, the company will still offer one of the more attractive dividends in the healthcare sector. Which of these coronavirus-focused stocks is the better pick for investors over the long term? Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. This is also one of the most significant differences noted between the Pfizer-BioNTech and Moderna vaccine. Returns as of 03/05/2021. In addition to the vaccinations, we should wear masks, follow hand hygiene, and social distancing to help our community fight the disease. We’re motley! The case for Moderna. Both Moderna and Pfizer are equally efficient and provide an immune response against the Coronavirus strain that causes COVID-19. Moderna's initial public offering (IPO) in December 2018 was the biggest ever for a biotech stock. Studies on the Moderna vaccine also claim that the vaccine may interfere and cause allergic reactions in people with facial fillers. This process will also involve watching reports that the immunized population is starting to contract COVID-19 disease in larger numbers. While both vaccines have nearly similar immune responses, the Pfizer vaccine showed the efficacy of 95%, and the Moderna showed the efficacy of 94%. Here is what you need to know about how the Pfizer and Moderna vaccines compare. Pfizer shareholders who retain their shares of Viatris, the newly formed entity resulting from the Upjohn-Mylan merger, will receive a combined dividend from Viatris and Pfizer that's roughly equivalent to Pfizer's current dividend. Here's how Moderna and Pfizer compare. If this mRNA approach works for one disease, it will likely work for many others. After the thawing, the Pfizer vaccine must be administered within five days. The biotech has also secured a supply deal with Canada and is in discussions about an agreement with the European Commission. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries. Both vaccines are now tested against the newly discovered, highly contagious COVID-19 strains. The company is evaluating five other mRNA vaccine candidates in clinical testing. Investors, in turn, are banking on Moderna's success. My view is that both Moderna and Pfizer are attractive stocks. Author: Marcelino Benito (KHOU) The company markets a long list of products, featuring more than half a dozen on track for blockbuster sales this year. Author: Thuy Lan Nguyen The fragment stimulates antibody production, which eventually provides an immune response against the virus. Emergency Use Authorization (EUA) by late November. These supply agreements are contingent upon mRNA-1273 proving to be safe and effective. If not complete elimination, both vaccines seemed to reduce the risk of severe COVID-19 disease. Currently, the storage requirement is one of the most significant factors for Pfizer’s vaccine distribution. Its pipeline also includes seven mRNA programs targeting conditions such as cancer and coronary artery disease. The big pharma stock is less risky than Moderna. However, the company has bought several ultra-cold storage freezers to ease the vaccine distribution burden. The vaccines are very similar in terms of efficacy and both require a priming dose followed by a booster a few weeks later. Now Moderna’s COVID-19 vaccine has joined Pfizer’s in being administered to healthcare workers and residents in long-term care facilities in the United States. AstraZeneca can be stored at normal refrigerator temperatures, possibly making distribution a … With so many other vaccines in the market, it can be confusing to have two different vaccines and possibly, having more to come in the United States to join the race to get people immunized against the same virus. The Moderna’s vaccine must be shipped at -4 Fahrenheit, the temperature in a regular refrigerator. Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer. During the vaccines’ phase-3 clinical trials, both have shown astonishing and nearly equivalent results with close to 95% of efficacy. Moderna (NASDAQ:MRNA) makes one of the vaccine candidates in the running. Find out more about our Injury Case Management services or our Occupational Health Programs. Employee Health Medical Management Experts. Both vaccines were measured based on providing immune response and shipping symptomatic COVID infection. Pfizer also boasts one of the deepest pipelines in the biopharmaceutical industry. If the FDA authorizes Moderna's COVID-19 vaccine, 5.9 doses could be shipped out by next week. 3 Reasons to Buy Pfizer and 1 Reason to Sell, 3 Popular Stocks Billionaires Can't Stop Selling, Copyright, Trademark and Patent Information. The minimum vaccine order for direct shipment from McKesson is 100 doses. Both companies have recently begun testing their vaccine on participants of 12- to 17-year-olds.